We are live on ! Find out more
INGN icon

Inogen

134 hedge funds and large institutions have $409M invested in Inogen in 2022 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 66 increasing their positions, 29 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

128% more repeat investments, than reductions

Existing positions increased: 66 | Existing positions reduced: 29

6.4% less ownership

Funds ownership: 96.85%90.45% (-6.4%)

8% less funds holding

Funds holding: 145134 (-11)

24% less capital invested

Capital invested by funds: $538M → $409M (-$129M)

33% less funds holding in top 10

Funds holding in top 10: 32 (-1)

43% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 21

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $49K

Holders
134
Holders Change
-11
Holders Change %
-7.59%
% of All Funds
2.15%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
12
Increased
66
Reduced
29
Closed
21
Calls
Puts
$49K
Net Calls
-$49K
Net Calls Change
+$221K

INGN Hedge Fund Activity: Q4 2022 in Review

134 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in Inogen (INGN) for Q4 2022, worth a combined $409M — down 24% from $538M a quarter earlier.

Sellers outnumbered buyers: 21 funds closed out of INGN and 12 opened new positions — a net loss of 9 holders — while 29 trimmed existing stakes and 66 added.

The largest buyer was Morgan Stanley, adding an estimated $11.9M. The largest seller was Brown Capital Management, cutting an estimated $20.8M.

  • 134 institutional investors held Inogen (INGN) as of Q4 2022, down from 145 in Q3 2022.
  • Funds reported $409M of Inogen stock for Q4 2022, down 24% quarter-over-quarter.
  • 12 funds opened new Inogen positions in Q4 2022 and 21 closed out, a net change of -9 holders.
  • The largest Inogen buyer in Q4 2022 was Morgan Stanley, an estimated $11.9M added.
  • The largest Inogen seller in Q4 2022 was Brown Capital Management, an estimated $20.8M sold.

Based on aggregated 13F filings for Q4 2022.